While this trend was not seen at the earliest time points, we did notice expansion of a CD11blo population at Days 3 and 7 in mice carrying IRF5-positive OS or BC tumors that likely represent transitional myeloid cells (Fig. 4a,b). The gene discussed is IRF5; the disease is breast cancer.